Analyst Viewpoint
The global intracranial stents market size is driven by increase in incidence of neurological disorders. The demand for intracranial stents is growing with the rise in cases of aneurysms, strokes, and intracranial stenosis.
Technological advancements in intracranial stent design and materials are likely to boost the global market demand in the near future. Vendors are developing self-expanding stents and bioresorbable stents to improve the effectiveness and safety of intracranial stents.
Governments and private organizations are focused on increasing awareness about the availability of treatment options for neurological disorders. This is leading to early detection and intervention of these disorders, thereby driving the intracranial stents market value.
Intracranial stents, also known as cerebral vessel stents, are implants that open blocked arteries, allowing improved blood to flow to the brain. These stents are widely used in the management of cerebral vascular diseases.
There are roughly four generations of intracranial stent designs: the balloon expandable stent, the open cell self-expandable stent, the close cell self-expandable stent, and the flow diverting stent.
Technological innovation and increase in preference for intracranial stents for the treatment of intracranial stenosis and management of stroke are likely to drive the intracranial stents market statistics in the next few years.
Rapid rise in geriatric population, increase in incidence of chronic neurological diseases, and surge in investment in research and development activities in the field of stroke management and chronic neurological diseases are also boosting the demand for intracranial stents.
However, tight budgetary constraints faced by intracranial stent manufacturers and healthcare service providers are key factors restraining the market revenue.
| Attribute | Detail |
|---|---|
| Drivers |
|
Neurological disorders are a major and increasing global health challenge, which accounts for a substantial portion of the disease burden worldwide. According to a study published in 2022 in the journal Frontiers, globally, in 2019, there were nearly 10 million deaths and 349 million DALYs due to neurological disorders.
Among the 18 neurological disorders, stroke was the biggest contributor to DALYs and deaths, followed by neonatal encephalopathy due to birth asphyxia and trauma.
High demand for minimally invasive procedures and availability of embolic devices are expected to spur the intracranial stents market growth in the near future. Stenting is a minimally invasive procedure.
It does not require a large, open incision in the body. Intracranial stents offer benefits such as reduced recovery time, lower risk of complications, and shorter hospital stays.
Rapid innovation in the field of self-expanding stents and improvement in the flexibility of the stents are primary influences of the intracranial stents industry. There have been major evolutions in the designs of intracranial stents throughout the years.
The self-expandable design makes the stent deploying process more smooth and gentle. It can also avoid plaques on site being meshed into small emboli by the crushing force from the expanding process.
Intracranial stent companies are developing stents with biologically friendly coatings. They are using inorganic coating materials such as titanium nitride, titanium oxide, or titanium oxynitride. Regenerative stent technologies are gaining traction as they help reduce the risk of complications associated with traditional stents, such as restenosis (re-narrowing of the blood vessel) and thrombosis (blood clot formation).
According to the latest intracranial stents market trends, the self-expanding stents product type segment accounted for a prominent share in 2022.
Self-expanding stents help reduce the incidence of deployment failure, parental artery dissertation, and vessel perforation. These stents are the most commonly placed stents in patients with femoropopliteal disease.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the latest intracranial stents market forecast, North America is expected to account for a leading share from 2023 to 2031, followed by Europe. North America held largest share in 2022.
High prevalence of neurological diseases coupled with the presence of sophisticated healthcare infrastructure and rising per capita healthcare expenditure are boosting the market dynamics of the region.
Strong research and development activities are promoting the development of new neurology devices. This, in turn, is contributing to the significant market share in North America.
Major manufacturers are developing innovative stent designs for intracranial aneurysm treatment. They are adopting regenerative technologies to develop stents that are biocompatible with the body's tissues.
Penumbra, Inc., Medtronic, Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson Services, Inc., and Cook Medical are key companies in this market.
The intracranial stents market report highlights these companies in terms of parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Value in 2022 (Base Year) | US$ 2.2 Bn |
| Market Forecast Value in 2031 | US$ 3.4 Bn |
| Growth Rate (CAGR) | 5.2% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon Request |
| Pricing | Available upon Request |
It was valued at US$ 2.2 Bn in 2022
It is projected to grow at a CAGR of 5.2% from 2023 to 2031
increase in incidence of neurological disorders and technological advancements in intracranial stent design and materials
North America was the most lucrative region in 2022
Penumbra, Inc., Medtronic, Stryker Corporation, Boston Scientific Corporation, Johnson & Johnson Services, Inc., and Cook Medical
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Intracranial Stents Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Intracranial Stents Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Intracranial Stents Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Self-expanding Stents
6.3.2. Balloon Expanding Stents
6.3.3. Stent-assisted Coil Embolization
6.4. Market Attractiveness Analysis, by Product Type
7. Global Intracranial Stents Market Analysis and Forecast, by Disease Indication
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Disease Indication, 2017–2031
7.3.1. Intracranial Stenosis
7.3.2. Brain Aneurysm
7.4. Market Attractiveness Analysis, by Disease Indication
8. Global Intracranial Stents Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Intracranial Stents Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Intracranial Stents Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2017–2031
10.3.1. Self-expanding Stents
10.3.2. Balloon Expanding Stents
10.3.3. Stent-assisted Coil Embolization
10.4. Market Value Forecast, by Disease Indication, 2017–2031
10.4.1. Intracranial Stenosis
10.4.2. Brain Aneurysm
10.5. Market Value Forecast, by End-user, 2017–2031
10.5.1. Hospitals
10.5.2. Ambulatory Surgical Centers
10.5.3. Others
10.6. Market Value Forecast, by Country, 2017–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product Type
10.7.2. By Disease Indication
10.7.3. By End-user
10.7.4. By Country
11. Europe Intracranial Stents Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2017–2031
11.3.1. Self-expanding Stents
11.3.2. Balloon Expanding Stents
11.3.3. Stent-assisted Coil Embolization
11.4. Market Value Forecast, by Disease Indication, 2017–2031
11.4.1. Intracranial Stenosis
11.4.2. Brain Aneurysm
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Others
11.6. Market Value Forecast, by Country/Sub-region, 2017–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Disease Indication
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Intracranial Stents Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2017–2031
12.3.1. Self-expanding Stents
12.3.2. Balloon Expanding Stents
12.3.3. Stent-assisted Coil Embolization
12.4. Market Value Forecast, by Disease Indication, 2017–2031
12.4.1. Intracranial Stenosis
12.4.2. Brain Aneurysm
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Disease Indication
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Intracranial Stents Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2017–2031
13.3.1. Self-expanding Stents
13.3.2. Balloon Expanding Stents
13.3.3. Stent-assisted Coil Embolization
13.4. Market Value Forecast, by Disease Indication, 2017–2031
13.4.1. Intracranial Stenosis
13.4.2. Brain Aneurysm
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Disease Indication
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Intracranial Stents Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product Type, 2017–2031
14.3.1. Self-expanding Stents
14.3.2. Balloon Expanding Stents
14.3.3. Stent-assisted Coil Embolization
14.4. Market Value Forecast, by Disease Indication, 2017–2031
14.4.1. Intracranial Stenosis
14.4.2. Brain Aneurysm
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Disease Indication
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Penumbra, Inc.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Medtronic
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Stryker Corporation
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Boston Scientific Corporation
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Johnson & Johnson Services, Inc.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Cook Medical
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
List of Tables
Table 01: Global Intracranial Stents Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 02: Global Intracranial Stents Market Size (US$ Mn) Forecast, by Disease Indication, 2017–2031
Table 03: Global Intracranial Stents Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 04: Global Intracranial Stents Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 05: North America Intracranial Stents Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 06: North America Intracranial Stents Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 07: North America Intracranial Stents Market Size (US$ Mn) Forecast, by Disease Indication, 2017–2031
Table 08: North America Intracranial Stents Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 09: Europe Intracranial Stents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 10: Europe Intracranial Stents Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 11: Europe Intracranial Stents Market Size (US$ Mn) Forecast, by Disease Indication, 2017–2031
Table 12: Europe Intracranial Stents Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 13: Asia Pacific Intracranial Stents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 14: Asia Pacific Intracranial Stents Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 15: Asia Pacific Intracranial Stents Market Size (US$ Mn) Forecast, by Disease Indication, 2017–2031
Table 16: Asia Pacific Intracranial Stents Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 17: Latin America Intracranial Stents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Intracranial Stents Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 19: Latin America Intracranial Stents Market Size (US$ Mn) Forecast, by Disease Indication, 2017–2031
Table 20: Latin America Intracranial Stents Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Middle East & Africa Intracranial Stents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 22: Middle East & Africa Intracranial Stents Market Size (US$ Mn) Forecast, by Product Type, 2017–2031
Table 23: Middle East & Africa Intracranial Stents Market Size (US$ Mn) Forecast, by Disease Indication, 2017–2031
Table 24: Middle East & Africa Intracranial Stents Market Size (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Intracranial Stents Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031
Figure 02: Global Intracranial Stents Market Revenue (US$ Mn), by Product Type, 2022
Figure 03: Global Intracranial Stents Market Value Share, by Product Type, 2022
Figure 04: Global Intracranial Stents Market Revenue (US$ Mn), by Disease Indication, 2022
Figure 05: Global Intracranial Stents Market Value Share, by Disease Indication, 2022
Figure 06: Global Intracranial Stents Market Revenue (US$ Mn), by End-user, 2022
Figure 07: Global Intracranial Stents Market Value Share, by End-user, 2022
Figure 08: Global Intracranial Stents Market Value Share, by Region, 2022
Figure 09: Global Intracranial Stents Market Value (US$ Mn) Forecast, 2023–2031
Figure 10: Global Intracranial Stents Market Value Share Analysis, by Product Type, 2022–2031
Figure 11: Global Intracranial Stents Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 12: Global Intracranial Stents Market Value Share Analysis, by Disease Indication, 2022–2031
Figure 13: Global Intracranial Stents Market Attractiveness Analysis, by Disease Indication, 2023–2031
Figure 14: Global Intracranial Stents Market Value Share Analysis, by End-user, 2022–2031
Figure 15: Global Intracranial Stents Market Attractiveness Analysis, by End-user, 2023–2031
Figure 16: Global Intracranial Stents Market Value Share Analysis, by Region, 2022–2031
Figure 17: Global Intracranial Stents Market Attractiveness Analysis, by Region, 2023–2031
Figure 18: North America Intracranial Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 19: North America Intracranial Stents Market Attractiveness Analysis, by Country, 2023–2031
Figure 20: North America Intracranial Stents Market Value Share Analysis, by Country, 2022–2031
Figure 21: North America Intracranial Stents Market Value Share Analysis, by Product Type, 2022–2031
Figure 22: North America Intracranial Stents Market Value Share Analysis, by Disease Indication, 2022–2031
Figure 23: North America Intracranial Stents Market Value Share Analysis, by End-user, 2022–2031
Figure 24: North America Intracranial Stents Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 25: North America Intracranial Stents Market Attractiveness Analysis, by Disease Indication, 2023–2031
Figure 26: North America Intracranial Stents Market Attractiveness Analysis, by End-user, 2023–2031
Figure 27: Europe Intracranial Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 28: Europe Intracranial Stents Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 29: Europe Intracranial Stents Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 30: Europe Intracranial Stents Market Value Share Analysis, by Product Type, 2022–2031
Figure 31: Europe Intracranial Stents Market Value Share Analysis, by Disease Indication, 2022–2031
Figure 32: Europe Intracranial Stents Market Value Share Analysis, by End-user, 2022–2031
Figure 33: Europe Intracranial Stents Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 34: Europe Intracranial Stents Market Attractiveness Analysis, by Disease Indication, 2023–2031
Figure 35: Europe Intracranial Stents Market Attractiveness Analysis, by End-user, 2023–2031
Figure 36: Asia Pacific Intracranial Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 37: Asia Pacific Intracranial Stents Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 38: Asia Pacific Intracranial Stents Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 39: Asia Pacific Intracranial Stents Market Value Share Analysis, by Product Type, 2022–2031
Figure 40: Asia Pacific Intracranial Stents Market Value Share Analysis, by Disease Indication, 2022–2031
Figure 41: Asia Pacific Intracranial Stents Market Value Share Analysis, by End-user, 2022–2031
Figure 42: Asia Pacific Intracranial Stents Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 43: Asia Pacific Intracranial Stents Market Attractiveness Analysis, by Disease Indication, 2023–2031
Figure 44: Asia Pacific Intracranial Stents Market Attractiveness Analysis, by End-user, 2023–2031
Figure 45: Latin America Intracranial Stents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 46: Latin America Intracranial Stents Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 47: Latin America Intracranial Stents Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 48: Latin America Intracranial Stents Market Value Share Analysis, by Product Type, 2022–2031
Figure 49: Latin America Intracranial Stents Market Value Share Analysis, by Disease Indication, 2022–2031
Figure 50: Latin America Intracranial Stents Market Value Share Analysis, by End-user, 2022–2031
Figure 51: Latin America Intracranial Stents Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 52: Latin America Intracranial Stents Market Attractiveness Analysis, by Disease Indication, 2023–2031
Figure 53: Latin America Intracranial Stents Market Attractiveness Analysis, by End-user, 2023–2031
Figure 54: Middle East & Africa Intracranial Stents Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 55: Middle East & Africa Intracranial Stents Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 56: Middle East & Africa Intracranial Stents Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 57: Middle East & Africa Intracranial Stents Market Value Share Analysis, by Product Type, 2022–2031
Figure 58: Middle East & Africa Intracranial Stents Market Value Share Analysis, by Disease Indication, 2022–2031
Figure 59: Middle East & Africa Intracranial Stents Market Value Share Analysis, by End-user, 2022–2031
Figure 60: Middle East & Africa Intracranial Stents Market Attractiveness Analysis, by Product Type, 2023–2031
Figure 61: Middle East & Africa Intracranial Stents Market Attractiveness Analysis, by Disease Indication, 2023–2031
Figure 62: Middle East & Africa Intracranial Stents Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Intracranial Stents Market
*86 figures and 60 tables includes